Thymocyte Drug Target of Immune Reconstitution

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43AI060447-01
Agency Tracking Number: AI060447
Amount: $270,181.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solicitation Year: 2004
Solicitation Topic Code: N/A
Solicitation Number: PHS2004-2
Small Business Information
ORPHAGEN PHARMACEUTICALS, 5310 EASTGATE MALL, SAN DIEGO, CA, 92121
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 SCOTT Thacher
 (858) 625-0540
 smt@orphagen.com
Business Contact
 TIM SCOTT
Phone: (858) 625-0540
Email: TSCOTT@ORPHANGEN.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): The long-term objective of this proposal is to develop the first class of small molecule, orally-bioavailable drugs that increases T cell production from the thymus and enhances immune reconstitution in AIDS and other

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government